JPS6083598A - Method for measuring substrate or enzyme - Google Patents
Method for measuring substrate or enzymeInfo
- Publication number
- JPS6083598A JPS6083598A JP18893583A JP18893583A JPS6083598A JP S6083598 A JPS6083598 A JP S6083598A JP 18893583 A JP18893583 A JP 18893583A JP 18893583 A JP18893583 A JP 18893583A JP S6083598 A JPS6083598 A JP S6083598A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- adenine dinucleotide
- reduced form
- nicotinamide adenine
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、チューブやセルを汚すことなく正確かつ迅速
に基質又は酵素を測定することを可能とした方法に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method that enables accurate and rapid measurement of substrates or enzymes without contaminating tubes or cells.
臨床検査室で化体物質を可視部にて測定する方法を発色
方法の点から見ると、過酸化水素を発生させてベルオキ
シダーゼを用い又は非酵素的に赤〜緑色に発色させる方
法、脱水素酵素を利用してNΔDにコチンアミドアデニ
ンジヌクレオチド)/NADHにコチンケミドアデニン
ジヌクレオチド還元型)又はNADP にコチンアミト
アデニンジヌクレオチドホスフェー11/NADI)H
にコチンアミドアデニンジヌクレオチドホスフェート還
元型)の変化を紫外部で1jtlJ定する方法及びNA
DH,NADPHをホルマザン発色に導く方法に大別さ
れる。From the perspective of color development methods, methods for measuring metabolized substances in visible areas in clinical laboratories include methods that generate hydrogen peroxide and develop a red to green color using peroxidase or non-enzymatically, and dehydrogenation. Using enzymes, NΔD (cotinamide adenine dinucleotide)/NADH (cotinamide adenine dinucleotide reduced form) or NADP (cotinamide adenine dinucleotide phosphate 11/NADI)H
Method for determining changes in cotinamide adenine dinucleotide phosphate (reduced form) under ultraviolet light and NA
It is roughly divided into methods that lead DH and NADPH to formazan color development.
一方、近年、自動分析の進歩とあいまって、グルコース
オキシダーゼ、ウリカーセ、コレステロールオキシダー
ゼ、ピルビン酸オキシダー、ゼ等の過酸化水素を生成さ
せることのできる酵素が数多く開発され、生体物質を容
易に且つ迅速に測定することが可能となってきた。On the other hand, in recent years, along with advances in automatic analysis, many enzymes that can generate hydrogen peroxide, such as glucose oxidase, uricase, cholesterol oxidase, pyruvate oxidase, etc., have been developed, and biological materials can be easily and quickly processed. It has become possible to measure
自動分析装置による測定では上記した発色法のうち、過
酸化水素発色法及びN A I) / NΔl1l(又
はNADP/NADPI−1)を検出系に用いる紫外部
吸収法のいずれも適用可能である。For measurement using an automatic analyzer, of the above-mentioned color methods, both the hydrogen peroxide color method and the ultraviolet absorption method using NADP/NADPI-1 as a detection system are applicable.
また、上記したホルマザン発色法は、過酸化水素発色に
導くことの出来ない脱水素酵素を利用する反応に対して
適用されるもので、例えばL l) 11(乳酸脱水素
酵素)を可視部で測定する場合にド記の反応式に示され
るようにLDHによって生したNADHをPMS (フ
ェナジンメトスルフェート)、1−メトキシI)MS(
1−メトキシフェナジンメトスルフェート)等の電子伝
達体を介して紫色のホルマザン発色に導くものである。Furthermore, the formazan coloring method described above is applied to reactions that utilize dehydrogenases that cannot lead to hydrogen peroxide coloring, for example, L l) 11 (lactate dehydrogenase) in the visible region. When measuring, as shown in the reaction formula below, NADH produced by LDH is treated with PMS (phenazine methosulfate), 1-methoxy I) MS (
1-methoxyphenazine methosulfate) etc., which leads to the development of a purple formazan color.
LDH
N T B N T B H2
(式中、NTBはニトロテトラゾリウムブルー、N T
B H2はニトロテトラゾリウムブルー還元型である
。)
しかし、ホルマザン発色法では、ホルマザン発色物質に
よるチューブやセルに対する沈着が強くそれらの汚れの
問題を惹起するため自動分析には殆ど用いられず、用手
法をもちいざるを得ないという欠点があった。LDH N T B N T B H2 (wherein, NTB is nitrotetrazolium blue, N T
B H2 is the reduced form of nitrotetrazolium blue. ) However, the formazan coloring method had the disadvantage that it was rarely used for automatic analysis because the formazan coloring substance deposited strongly on tubes and cells, causing problems with contamination, and manual methods had to be used. .
本発明は、上述したホルマザン発色法の欠点を解消すべ
〈発明されたもので、脱水素酵素反応で生成したNAD
H(又はNADPI−1)を電子伝達体を介して過酸化
水素発色に導くことを可能としたものである。本発明方
法の要点を式で示せは次の如くとなる。The present invention aims to eliminate the drawbacks of the above-mentioned formazan coloring method.
This makes it possible to lead H (or NADPI-1) to hydrogen peroxide color development via an electron carrier. The main points of the method of the present invention can be expressed as follows.
以下余白
脱水素酵素
NAD (P) NAD (P)H
(上式中、NAD (P)はNAD又はNADPを息味
し、NAD (P)HはNADH又はNADPI(を怠
味するものである。)
この生成したI4□qを色原体を用いて酵素的又は非酵
素的に発色させる点に特徴を有するものである。要する
に 還元型電子伝達体が反応液中の溶存酸素によって元
の酸化型に復帰する際、H,O,を生ずる点に着目する
ことによって本発明の完成に至ったものである。The following margin dehydrogenase NAD (P) NAD (P) H (In the above formula, NAD (P) is NAD or NADP, and NAD (P) H is NADH or NADPI. ) This is characterized in that the generated I4□q is colored enzymatically or non-enzymatically using a chromogen.In short, the reduced electron carrier is converted to its original oxidized form by dissolved oxygen in the reaction solution. The present invention was completed by paying attention to the fact that H and O are generated when returning to .
本発明は、従来のホルマザン法の欠点を解消し、チュー
フ゛やセルをンηすことがなくなり、自d!Iノ分析に
ものりやすくした基質又は酵素の測定法を提供すること
を目的とする。The present invention eliminates the drawbacks of the conventional formazan method, eliminates the need for tubes and cells, and improves efficiency. The purpose of the present invention is to provide a method for measuring substrates or enzymes that can be easily applied to I/O analysis.
本発明の要旨は、N A D H又はNAD I) H
又はこれらの誘導体を経由して基質又は酵素を測定する
方法において、電子伝達体を介して過酸化水素を生成せ
しめその生成した過酸化水素を酵素的又は非酵素的に発
色せしめて定量することを6徴とする基質又は酵素の測
定法に存する。The gist of the present invention is that N A D H or N A D I) H
Alternatively, in a method for measuring substrates or enzymes via these derivatives, hydrogen peroxide is generated via an electron carrier and the generated hydrogen peroxide is colored enzymatically or non-enzymatically to quantify it. It consists of a method for measuring substrates or enzymes with six characteristics.
N A D H又はN A D P Hの誘導体とは、
3 アセチルピリジンアデニンジヌクレオチ1−還元型
の他、例えばBRUCE M、ANDIER3ON。What is a derivative of N A D H or N A D P H?
3 Acetylpyridine adenine dinucleotide 1-reduced form, such as BRUCE M, ANDIER3ON.
et al J、Biol、Chem、、2:14、1
219 (1959) 、 131ン UCI’: M
、Δ NDER3ON、eL a l J、+3i o
1.Chem、、234.1226 (1959)等
に記載されている還元型のものをいう。et al J, Biol, Chem, 2:14, 1
219 (1959), 131 UCI': M
, Δ NDER3ON, eL a l J, +3i o
1. Chem, 234.1226 (1959), etc., refers to the reduced form.
本発明で用いられる電子伝達体としては、フェナジンメ
トスルフェート (PMS) 、1−メトキノフェナジ
ンメトスルフェート(1−メトキシPMS) 、フェナ
ジンエトスルフェート(PES)等をあげることかでき
、又ジアボラーセのごとき酵素も包含される。Examples of the electron carrier used in the present invention include phenazine methosulfate (PMS), 1-methoquinophenazine methosulfate (1-methoxyPMS), phenazine ethosulfate (PES), and diabolase. Also included are enzymes such as.
本発明方法における非酵素的発色方法としては、公知の
方法が採用出来るが、例えばTi−PAR法(松原チヨ
等、分析化学、Vol、29.1980年、759〜7
64頁)並びにTi−X0法、T i −CA S法、
T i −E D T A法及びC。As the non-enzymatic coloring method in the method of the present invention, known methods can be adopted, such as the Ti-PAR method (Chiyo Matsubara et al., Analytical Chemistry, Vol. 29, 1980, 759-7
page 64) and Ti-X0 method, Ti-CAS method,
T i -E D T A method and C.
−EDTA法(松原チヨ等、薬学雑誌、Vol。-EDTA method (Chiyo Matsubara et al., Pharmaceutical Journal, Vol.
97.1977年、41〜45頁)等を用いればよい。97. 1977, pp. 41-45).
本発明方法が適用される反応の例としては次の如きもの
をあげることができる。Examples of reactions to which the method of the present invention is applicable include the following.
■グルコースの定量
(al ムタロターゼ
α−グルコース β−グルコース
グルコースデヒドロゲナーゼ
(bl へ中ソキナーゼ
グルコース−6−リン酸脱水素酵素
■コレステロールの測定
(a)総コレステロールの測定
コレステロールエステラーゼ
エステル型 −ン遊離型コレステロールコレステロール
コレステロールデヒドロゲナーゼ
NAD (P) NAD (P) H
(bl遊離型コレステロールの測定
コレステロールデヒドロゲナーゼ
NAD (P) NAD (P)H
以下余白
■胆汁酸の測定
3α−ヒドロキシステロイドデヒドロゲナーゼNAD
(P) NAD (P)Ll
■乳酸の測定
乳酸脱水素酵素
NAD (P) NAD (P)II
■乳酸脱水素酵素(LDH)の/I11[定LDfイ
NAD (P) NAD (1))lI■G ○ ゴ・
G l)”Fの訊り定し−アスパラギン酸十α〜ケト
グルクールOT
−〉オキザロ酢酸+Lーグルタミン酸
L−アラニン+αーケ1ークルタール
C I) T
−〉ピルビン酸十しーグルタミン酸
グルタミン酸テヒドロゲナーセ
NAD (P) NAD (P)H
以下余白
■タレアチンキナーゼ(CK)の?)Ill定K
クレアチンリン酸−一一一→クレアヂン+A T+)+
ADP
ヘキソキナーゼ
ATP+グルコース ΔD l−’ +グルコースー
6−リン酸
グルコース−6−リン酸脱水素酵素
(上式中、ATPはアデノシンlーリボスフェ−1・、
ADPはアデノシンシボスフエートである。)上記の反
応の如く生成したN A l) II又はNΔ1〕P
I−1を電子伝達体を介して過酸化水素発色に導くもの
である。すなわち、過酸化水素をペルオキシダーゼの存
在下で4−アミノアンチピリン及び水素供与体を反応さ
せて有色の発色物質を生成させる。この水素供与体とし
ては、フェノール、2。■ Determination of glucose (al mutarotase α-glucose β-glucose glucose dehydrogenase (bl hemokinase glucose-6-phosphate dehydrogenase ■ Measurement of cholesterol (a) Measurement of total cholesterol cholesterol esterase ester type -n free cholesterol Cholesterol Cholesterol Dehydrogenase NAD (P) NAD (P) H (bl Measurement of Free Cholesterol Cholesterol Dehydrogenase NAD (P) NAD (P)H Below margin ■ Measurement of Bile Acids 3α-Hydroxysteroid Dehydrogenase NAD
(P) NAD (P)Ll ■Measurement of lactic acid Lactate dehydrogenase NAD (P) NAD (P)II ■Lactic dehydrogenase (LDH) /I11 [Constant LDf I NAD (P) NAD (1))lI ■G ○ Go・
G l) "Determination of F - Aspartic acid 10α ~ Ketoglucour OT -> Oxaloacetic acid + L - Glutamic acid L - Alanine + α - K1 - K1 - Kultal CI) T -> Pyruvate 10 - Glutamic acid glutamate Tehydrogenase NAD (P ) NAD (P)H Below margin ■ Taleatine kinase (CK)?) Ill constant K Creatine phosphate -111 → Creadine + A T+) +
ADP hexokinase ATP + glucose ΔD l-' + glucose-6-phosphate glucose-6-phosphate dehydrogenase (in the above formula, ATP is adenosine l-ribosphae-1,
ADP is adenosine sibosphate. ) N A l) II or NΔ1]P produced as in the above reaction
It leads I-1 to hydrogen peroxide color development via an electron carrier. That is, hydrogen peroxide is reacted with 4-aminoantipyrine and a hydrogen donor in the presence of peroxidase to produce a colored substance. As this hydrogen donor, phenol, 2.
4−ソクロロフェノール、p−クロルフェノール、N.
N−ジメチルメタトルイジン、N,N−ジメチルメタト
ルイジン、TOOS (N−エチル−N−(2−ヒドロ
キシ−3−スルホプロピル)−m−トルイジンナトリウ
ム)等が用いられる。また、過酸化水素を発色させるだ
めのMBTH(塩酸3−メチル−2−ヘンゾチアゾリノ
ンヒドラゾン)やジメチルアニリン、ジエチルアニリン
等の組合ゼも可能である。更に、ペルオキシダーゼ存在
下で第3因子(4−アミノアンチピリン等)なしに過酸
化水素を発色させることのできる発色剤(フェニレンジ
アミン及びその誘導体、MCDP、BCMA等)を用い
ることも出来る。4-Sochlorophenol, p-chlorophenol, N.
N-dimethyl metatoluidine, N,N-dimethyl metatoluidine, TOOS (N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-toluidine sodium), etc. are used. It is also possible to use combinations of MBTH (3-methyl-2-henzothiazolinone hydrazone hydrochloride), dimethylaniline, diethylaniline, etc., which do not cause hydrogen peroxide to develop color. Furthermore, it is also possible to use a coloring agent (phenylenediamine and its derivatives, MCDP, BCMA, etc.) that can color hydrogen peroxide in the presence of peroxidase without a third factor (4-aminoantipyrine, etc.).
以上の如き構成により、本発明方法によれば、従来のホ
ルマザン発色法の欠点が解消され、チューブやセルが発
色物質によって汚されることがなくなり、基質又は酵素
の測定が自動分析にのりやすくなるという効果を奏する
ものである。With the above configuration, the method of the present invention eliminates the drawbacks of the conventional formazan coloring method, eliminates the possibility of tubes and cells being contaminated by coloring substances, and facilitates automated analysis of substrates or enzymes. It is effective.
以下に実施例を挙げて本発明方法をさらに説明する。The method of the present invention will be further explained below with reference to Examples.
実施例I
NADHの定量
試薬組成
R・1液
リン酸緩衝液−−−−−50 mM, p H 7 、
01−メトキシP M S −一−−−−−0. 0
7 r口MR・2液
リン酸緩衝液−−−−−−− 5 0 0 m M.
p H 6 、04−アミノアンチピリン ー−−−1
.081rIMT O O S−−−−−−−−−−−
−−1. 8 m Mペルレオキシダーゼ−−−−−−
− − 12U/川p約5mMのNADHを含む試料を
炭酸水素すトリウムの溶液で115〜515に5段階希
釈し直線性を検討した。Example I NADH quantitative reagent composition R 1-liquid phosphate buffer --- 50 mM, pH 7,
01-MethoxyP M S -1---0. 0
7 r mouth MR/2 liquid phosphate buffer --- 5 00 m M.
pH 6, 04-aminoantipyrine---1
.. 081rIMT O O S------------
--1. 8 mM perleoxidase------
- - A sample containing about 5 mM NADH at 12 U/p was diluted in 5 steps from 115 to 515 with a solution of sodium bicarbonate, and linearity was examined.
試料50μlをR・l p(12m IIに加え、室温
に10分間放置後、R・2液1mβを加えた。次いで、
5分間放置して555nmで吸光度を測定した。50 μl of the sample was added to R・l p (12m II), and after leaving it at room temperature for 10 minutes, 1 mβ of R・2 solution was added.
The absorbance was measured at 555 nm after being left for 5 minutes.
測定結果を第1図に示したが、吸光度が1.5を示ず迄
、良好な直線性を示した。The measurement results are shown in FIG. 1, and showed good linearity until the absorbance was less than 1.5.
実施例2
グルコースの定量
試薬組成
R・1液
リンMi2fjjlll −−−−−−−−−−50m
M、p H7、0A T P −−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−2m MR−N A D −−−−−−−−−一
−−−−−−−−−−−−−−−−−−−−−−−−−
−−−−−−−2m Mへキソキナーゼ−−−−−−−
−−−−0、440/ m (1グルコース−6−リン
酸−
デヒドロゲナーゼー−−−−−−−−−−−一−4、5
U / m 1塩化マグネシウム−−−−−−−−−−
−−−−−−−−−−−−−−−−−2m Ml−メト
キシP M S −−−−−−−−−−−−0、015
m MR・2液
リン酸緩衝液−−−−−−−−500m M、p H6
、04−アミノアンチビリン−一−1、08111MT
OOS −−一−−−−−−−−−・−−−−−−−
−−−−21,8mN1ペルオキシダーゼ−−−−−−
−−−−■2 U / m 7!300mg/d1のグ
ルコース水溶液を水で115〜515に5段階希釈し、
直線性を検削した。Example 2 Glucose quantitative reagent composition R・1 liquid phosphorus Mi2fjjllll ----------50m
M, pH 7, 0A T P ------------------------
−−−−−−−−−−−−−−−−−−−−−−−−−
---2m MR-N A D ------
----------2m M hexokinase---
----0,440/m (1 glucose-6-phosphate-dehydrogenase----1-4,5
U/m 1 Magnesium Chloride---------
------------------2m Ml-MethoxyP M S -------0, 015
m MR 2-liquid phosphate buffer---500m M, pH 6
, 04-aminoantivirin-1-1, 08111MT
OOS--1--------------・-----
----21,8mN1 peroxidase---
----■2 U/m 7! A 300 mg/d1 glucose aqueous solution was diluted in 5 steps from 115 to 515 with water,
The linearity was inspected.
試料10μβをR−1液2 m lに加え、37℃で1
0分間反応後、R・2 lIE 1 mlを加えた。次
いで、5分間室温に放置後、555nmで吸光度を測定
した。その結果を第2図に示したが、グルコース300
■/d1まで良好な直線性を示した。Add 10 μβ sample to 2 ml of R-1 solution and incubate at 37°C.
After reacting for 0 minutes, 1 ml of R.2 IIE was added. Next, the absorbance was measured at 555 nm after being left at room temperature for 5 minutes. The results are shown in Figure 2.Glucose 300
Good linearity was shown up to (2)/d1.
本実施例での従来法(グルコースオキシターセ・過酸化
水素発色法)との相関はY=0.95x+10.r=0
.987 (n=30)であった。The correlation with the conventional method (glucose oxitase/hydrogen peroxide coloring method) in this example is Y=0.95x+10. r=0
.. 987 (n=30).
実施例3
遊離型コレステロールの測定
試薬組成
1k・ 11夜
トリス−リン酸緩衝液
−−−−−−100mM、pH8、6
N A D −−−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−20m Mコレステロール
デヒドロゲナーゼ(3β−ヒドロキシステロイドNAD
(P)オキシドレダクターゼ3−−−−−−−・−−
−一−−−−−−−−−−−−−−−−−−−−−−0
、8U / mβ1−メトキシP M S −−−−−
−−−−−−−−−−−−0、06m MトリトンX=
100 −−−−−−−−−−−−−−0 、 4%
R・2液
リン酸緩衝液−−−−−−−−500m M 、p H
6、04−アミノアンチビリン−−−−−−−−−1、
08m MT OOS −一−−−−−−−−−−−−
−−−−−−−−−−−−−−−−−−−−−1、8m
Mベルオキシダーゼ−−−−−−−−−−−−12U
/ m 1800mg/d1コレステロール溶液を水
で115〜515に5段階希釈して直線性を検a”lシ
た。Example 3 Reagent composition for measuring free cholesterol 1k/11 Tris-phosphate buffer---100mM, pH 8, 6 NAD--------------------- ---
−−−−−−−−−−−−20m M cholesterol dehydrogenase (3β-hydroxysteroid NAD
(P) Oxidoreductase 3---------・--
−1−−−−−−−−−−−−−−−−−−−−−0
, 8U/mβ1-methoxyPMS------
−−−−−−−−−−−0, 06m M Triton X=
100 −−−−−−−−−−−−−0, 4%
R・Two-liquid phosphate buffer---500mM, pH
6,04-aminoantivirine---1,
08m MT OOS -1------------
−−−−−−−−−−−−−−−−−−−−1, 8m
M peroxidase-------12U
/m 1800 mg/d1 cholesterol solution was diluted with water in 5 steps from 115 to 515 to check linearity.
試料10μβをR・1液1mlに加え、37℃で15分
間反応後、R・2液2m7!を加えた。次いで、5分間
室温に放置後、555nmで吸光度を測定した。その結
果を第3図にボしたが、ml L−ステロール600q
/d1まで良iJrな直線性をボした。Add 10 μβ sample to 1 ml of R・1 solution, react at 37°C for 15 minutes, and then add 2 ml of R・2 solution! added. Next, the absorbance was measured at 555 nm after being left at room temperature for 5 minutes. The results are shown in Figure 3.ml L-sterol 600q
I lost good iJr linearity until /d1.
実施例4
総コレステロールの測定
試薬組成
R・ 17夜
トリス−リン酸曝衝液
−−−−−−−−400mM、I) H8、(INAD
−−〜−”’−’−−−−−−−−−−−−−−−2[
) m Mコレステロールエステラーゼ 2 L−J
/ m /!コレステロールデヒドロゲナーゼ(3β−
ヒドロキシステロイドNAD(1))オキシドレダクタ
ーゼ)−’−’−”−”−’−”−”−−−−0,8U
/ m 7!1−メトキシP M 5−−0. 0らm
MトリトンX −100=−−0,4%
コール酸すトリウム −3701111? / eR・
21夜
リン酸緩衝液 −−−−−500m M 、p IIら
、04−アミノアンチピリン −−1、08m MT
OO5−−−−−−−−−−−−−−−一−−−−−−
−−1、8m Mペルオキシダーゼ−=−−−m−−−
−=−−−−−・−−−12U / mβ500mg1
dlのコレステロールをもつヒト血清を水で115〜5
15に5段階希釈し、実施例3と同様の操作で直線性を
検討した。その結果を第4Mに示したが、総コレステロ
ール500mg/d1以下で良好な直線性を示した。Example 4 Reagent composition for measuring total cholesterol R・17-night Tris-phosphoric acid buffer solution---400mM, I) H8, (INAD
−−〜−”'−'−−−−−−−−−−−−−−−2[
) m M cholesterol esterase 2 L-J
/ m /! Cholesterol dehydrogenase (3β-
Hydroxysteroid NAD (1)) oxidoreductase) -'-'-"-"-'-"-"--0,8U
/ m 7!1-methoxyP M 5--0. 0ram
M Triton X -100=--0.4% Thorium cholate -3701111? / eR・
21 night phosphate buffer -----500mM, p II et al., 04-aminoantipyrine --1, 08m MT
OO5--------------------
--1,8m M peroxidase-=---m---
−=−−−−−・−−−12U / mβ500mg1
Human serum with cholesterol of 115 to 5 dl is mixed with water.
15 in 5 steps, and linearity was examined in the same manner as in Example 3. The results are shown in the 4th M, and showed good linearity with total cholesterol being 500 mg/d1 or less.
実施例5
LDHの測定
試薬組成
R・1液
TrisIJ衝液−−−−−−−−−−−−−−−−−
−−−−−−−−−−−−−50m ML−乳酸−−−
一−−−−−−−−−−−−−−−−−−一一一−−−
−−−−−−−−−−−−−−一−−−−−−−・26
mMN A D −−−−−一−−−−−−−−−−−
−−−−−−−−−−−0、8m Ml−メトキシP
M S −−−−−−−−−−−−−−−0、05m
MpH8,4
1で・2液
リン酸緩衝液−・−−−−−−−−−−−−−−−−−
m−−−−−−−500m MT OO’S −−−−
−−−−−−−−−−−−−−−0、9m Mベルオキ
シダーゼー−−−−−−−−G U / m j’蓚酸
ナトリウム−−−−−−−−19m M4−アミンアン
チピリン −−−0、5411I MpH6,0
約3500相当のL D H標準血清を水で(15〜5
15に5段階希釈して直線性を検討した。Example 5 LDH measurement reagent composition R, 1-liquid TrisIJ buffer----------------------
-------------50m ML-lactic acid---
1------------------
−−−−−−−−−−−−−−−−−−・26
mMN A D −−−−−−−−−−−−−−
-------------0, 8m Ml-methoxy P
M S --------------0, 05m
MpH8,4 1 and 2-liquid phosphate buffer ----------------
m------500m MT OO'S -----
−−−−−−−−−−−−−−0,9m M peroxidase−−−−−−−G U / m j' Sodium oxalate−−−−−−−19m M4‐Amine Antipyrine ---0, 5411I MpH6.0 Add LDH standard serum equivalent to about 3500 with water (15-5
The linearity was examined by diluting the sample in 5 steps to 15%.
試料50p(4をR・1液1rnJに加え、37°(:
で正確に10分間加温後、R・2液2Inβを加えた。Add sample 50p (4 to 1rnJ of R・1 solution, 37° (:
After heating for exactly 10 minutes, R.2 solution 2Inβ was added.
次いで、5分間室温に71に直後、555r目11で吸
光度を測定した。その結果を第5図にン」<シたが、吸
光度0.3以下において良好な直線性を小した。The absorbance was then measured at the 555th point 11 immediately after leaving it at room temperature for 5 minutes. The results are shown in Figure 5, but the good linearity was poor at absorbances below 0.3.
第1図はN A D H量に対する直線性を>lくず図
面、第2図はグルコース量に対する直線性を小す図面、
第3図は遊離型コレステロール量に対する直線性を示す
図面、第4図は総コレスラ自コールr11に対する直線
性を示す図面及び第5図はLl、)II甲に対する直線
性を示す図面である。
HAD日
第2図
ツノしフ一人
第3図
迷梨型コレ入チロール
第4図
!r玉・コし入フ0−ルFigure 1 is a scrap diagram showing linearity with respect to the amount of N A D H, Figure 2 is a diagram showing linearity with respect to the amount of glucose,
FIG. 3 is a diagram showing the linearity with respect to the amount of free cholesterol, FIG. 4 is a diagram showing the linearity with respect to the total cholesterol self-call r11, and FIG. 5 is a diagram showing the linearity with respect to Ll, ) II A. HAD Day, Figure 2, Tsunoshifu Alone, Figure 3, Mysterious Pear-shaped Collection, Tyrol Figure 4! Full 0-full with r ball/coin
Claims (1)
由して基質又は酵素を測定する方法において、電子伝達
体を介して過酸化水素を生成せしめその生成した過酸化
水素を酵素的又は非酵素的に発色−已しめて定量するこ
とを特徴とする基質又は酵素の測定法。(1) In a method for measuring substrates or enzymes via NADH or NADPH or their derivatives, hydrogen peroxide is generated via an electron carrier and the generated hydrogen peroxide is colored enzymatically or non-enzymatically. - A method for measuring a substrate or enzyme, which is characterized in that it is quantified in a continuous manner.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18893583A JPS6083598A (en) | 1983-10-08 | 1983-10-08 | Method for measuring substrate or enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18893583A JPS6083598A (en) | 1983-10-08 | 1983-10-08 | Method for measuring substrate or enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6083598A true JPS6083598A (en) | 1985-05-11 |
Family
ID=16232469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP18893583A Pending JPS6083598A (en) | 1983-10-08 | 1983-10-08 | Method for measuring substrate or enzyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6083598A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153872A2 (en) * | 1984-02-29 | 1985-09-04 | Kyowa Medex Co. Ltd. | Method for the determination of the reduced form of nicotinamide adenine dinucleotide |
EP0206316A2 (en) * | 1985-06-26 | 1986-12-30 | Kyowa Medex Co. Ltd. | Method and test composition for determination of hydrogen peroxide |
-
1983
- 1983-10-08 JP JP18893583A patent/JPS6083598A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153872A2 (en) * | 1984-02-29 | 1985-09-04 | Kyowa Medex Co. Ltd. | Method for the determination of the reduced form of nicotinamide adenine dinucleotide |
EP0206316A2 (en) * | 1985-06-26 | 1986-12-30 | Kyowa Medex Co. Ltd. | Method and test composition for determination of hydrogen peroxide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4251629A (en) | Determination of hydrogen peroxide | |
JPH0687793B2 (en) | Method and reagent for colorimetric determination of analyte by enzymatic oxidation, and reductive chromogenic electron acceptor therefor | |
EP0775215B1 (en) | Chemiluminescence assays based on indoxyl substrates or thioindoxyl substrates | |
US4592996A (en) | Process for determining reduced form coenzymes | |
EP0116307B1 (en) | Composition, analytical element and method for the quantification of creatine kinase | |
US4271265A (en) | Method and reagent for the determination of glutamate-oxalacetate transaminase and glutamate-pyruvate transaminase | |
US5460948A (en) | Assay of salicylates or reduced pyridine nucleotides | |
JPH07121901B2 (en) | Novel urea derivative and measuring method using the same as a coloring component | |
US5286627A (en) | Method of high-sensitive analysis of bile acid and reagent composition for the analysis | |
JPS6083598A (en) | Method for measuring substrate or enzyme | |
EP0285998B1 (en) | Method and reagent for determination of dehydrogenase or its substrate | |
US5250420A (en) | Method and reagent for determination of dehydrogenase or its substrate | |
JPS5935599B2 (en) | Cholinesterase activity measurement method | |
US4816394A (en) | Quantitative analysis of 3α-hydroxysteroid and reagent useful therefor | |
Kayamori et al. | Enzymatic method for assaying uric acid in serum with a new tetrazolium salt produces water-soluble formazan dye | |
JPS61128899A (en) | Method of measuring substrate or enzyme | |
EP0245528B1 (en) | Quantitative analysis of 3 alpha-hydroxysteroid and reagent useful therefor | |
JPS6219100A (en) | Measurement of bile acid | |
JP3159273B2 (en) | Sorbitol measurement method and composition thereof | |
JPS59106299A (en) | Determination of reducing coenzyme | |
JP3034984B2 (en) | Highly sensitive method and composition for quantification of D-galactose | |
JPH02100699A (en) | Measurement of organism sample | |
JPH0662521B2 (en) | Novel choline derivative and method for assaying serum cholinesterase activity using the same | |
Komiyama et al. | Microassay of serum bile acids by an enzymatic cycling method | |
JPH0650997B2 (en) | New method for measuring cholinesterase activity |